ReviewFrontiers in neuroscience2018

HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction.

Yam Nath Paudel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.